ELREXFIO (elranatamab-bcmm) injection

FDA approved Anti-Cancer medicine ELREXFIO (elranatamab-bcmm) injection is available upon request. One can buy ELREXFIO online in India at the lowest price from the Medvitaz Pharma on request, if the medicine ELREXFIO is not (yet) registered or available in your country. For emergency product orders call 8750295029 (Mr. Neeraj Nagpal) or For enquires email urgent@pharmatourismhub.com.
Category: .

ELREXFIO (elranatamab-bcmm) injection

Elrexfio (elranatamab-bcmm) is a bispecific B-cell maturation antigen (BCMA)-directed CD3 T-cell engager used for the treatment of adult patients with relapsed or refractory multiple myeloma (MM) who have received at least 4 prior lines of therapy including an immunomodulatory agent, a proteasome inhibitor (PI), and an anti-CD38 monoclonal antibody.

Medicine Name: Elrexfio
API: Elranatamab-bcmm
Dosage Form & Strength: Injection: 76 mg/1.9 mL (40 mg/mL) and 44 mg/1.1 mL (40 mg/mL) in a single-dose vial
Manufactured By: Pfizer Inc.

How to make an enquiry for ELREXFIO (elranatamab-bcmm) injection?

ELREXFIO (elranatamab-bcmm) injection, FDA approved Anti-Cancer medicine is available upon request. Get best retail price of ELREXFIO (elranatamab-bcmm) injection from trusted pharmacy in Delhi, Gurgaon, Noida, Ghaziabad, Chandigarh, Dehradun, Jaipur, Agra, Vadodara Jn, Surat, Ahmedabad, Mumbai, Pune. Bhopal, Nagpur, Srinagar, Visakhapatnam, Vijayawada, Chennai, Bangalore, Thiruvananthapuram, Kerala, Guwahati, Kolkata, Mumbai. For emergency product orders call 8750295029 (Mr. Neeraj Nagpal) or For enquires email urgent@pharmatourismhub.com.

For advanced treatments in India, Medvitaz Pharma Solution can even help patient to discuss with doctor.

Elranatamab is indicated for the treatment of adults with relapsed or refractory multiple myeloma who have received at least four prior lines of therapy, including a proteasome inhibitor, an immunomodulatory agent, and an anti-CD38 monoclonal antibody

How and where to buy elranatamab?

Elranatamab-bcmm is a Generic Name for the trade name drug Elrexfio®. Elrexfio® is manufactured by Pfizer Inc. Elrexfio® is approved by the FDA. Date of first approval: August 14, 2023. Elrexfio® is supplied as Injections: 76 mg/1.9 mL (40 mg/mL) and 44 mg/1.1 mL (40 mg/mL) in a single-dose vial for subcutaneous use.

Elranatamab can be ordered on request direct from Medvitaz Pharma Solutions if the drug has not been approved or is not available in your country. We help you to get genuine, affordable and assurance of delivery at Delhi, Gurgaon, Noida, Ghaziabad, Chandigarh, Dehradun, Jaipur, Agra, Vadodara, Surat, Ahmedabad, Mumbai, Pune. Bhopal, Nagpur, Srinagar, Visakhapatnam, Vijayawada, Chennai, Bangalore, Thiruvananthapuram, Kerala, Guwahati, Kolkata, Mumbai. To get best retail price/cost of elranatamab in India, Call 8750295029 or Email urgent@pharmatourismhub.com.

    GET IN TOUCH
    CONTACT US

     777, Sector No. 37, Faridabad,
    Haryana: 121003. India.

    Mobile: +91 981174774
    WhatsApp: +91 8287471411